MedTrace Logo

Open Versus Endovascular Revascularization in Patients With End-stage Renal Disease

NCT03293589 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 77

Last updated 2020-03-26

No results posted yet for this study

Summary

Treatment of patients with end-stage renal disease and critical limb ischemia still poses challenges to vascular medicine due to limited survival, comorbidities and infrapopliteal involvement of arteriosclerosis in these patients.

Most optimal vascular therapy mode has not been finally decided in these patients.

Therefore retrospective analysis of patients receiving open surgical and endovascular revascularisation was performed.

Conditions

  • End-stage Renal Disease
  • Critical Limb Ischemia

Interventions

PROCEDURE

open revascularization

surgical revascularization (i.e. Bypass surgery)

PROCEDURE

endovascular revascularization

endovascular revascularization (stent, ballon angioplasty)

Sponsors & Collaborators

  • University Hospital Erlangen

    lead OTHER

Principal Investigators

  • Alexander Meyer, MD · University Hospital Erlangen, Department of Vascular Sugery

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-01
Primary Completion
2017-09-20
Completion
2017-10-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03293589 on ClinicalTrials.gov